Abstract

Within the biotech era, art that addresses life issues and brings biological life into the artistic context cannot avoid using biotechnology as the technology that facilitates interventions into living matter. Art not only intervenes in the living matter in laboratories but aims to show and cultivate tissues and various living cultures in the gallery space. Galleries have turned from spaces for showing artifacts into event spaces, performances and workshops. In this context, the idea of growing living entities within the artistic milieu testifies to a performative turn, a shift from representational to performative modes of art. Due to the imperative to perform, art which addresses biotechnology requires the presence of living tissues and other living substances in gallery spaces or spaces meant to show art to the public. The author identifies three sorts of microperformativity carried out by biotechnological art in the sense of managing life at the micro level. The most original of these and specific to art that works with living organisms involves the real-time action of living microorganisms or bioengineered tissues within the artistic context in full public view. For this sort of performativity, the artist induces microorganisms or engineered tissues to perform by themselves for the audience. Tratnik examines the project CellF by Guy Ben Ary as an example of such microperformativity.